Relaxin-2 improves diastolic function of pressure-overloaded rats via phospholamban by activating Akt

详细信息    查看全文

• 作者：Xin-xin Shuai¹ ; Yi-di Meng¹ ; Yong-xin Lu ; ^{yongxin_lu6@aliyun.com" class="auth_mail" title="E-mail the corresponding author} ; Guan-Hua Su ; Xiao-fang Tao ; Jun Han ; Su-Dan Xu ; Ping Luo
• 关键词：Relaxin ; Diastolic function ; Phospholamban ; Nuclear-target Akt
• 刊名：International Journal of Cardiology
• 出版年：2016
• 出版时间：1 September 2016
• 年：2016
• 卷：218
• 期：Complete
• 页码：305-311
• 全文大小：1078 K

文摘

Relaxin is a peptide hormone which has been demonstrated to be safe and has a therapeutic effect on acute heart failure in clinic trials. However, its effect on diastolic function is still unknown. The aims of the study were to determine whether relaxin could improve the diastolic function in pressure-overloaded rat model and to analyze potential mechanisms.

Methods and results

In the present study, a pressure-overloaded rat model induced by transaortic constriction (TAC) was established. Four weeks after TAC, echocardiography was performed and then all the rat models were randomly divided into 3 groups: models without intramyocardial injection (TAC), with intramyocardial injection of empty adenoviral vector (TAC + GFP) and adenoviral vector overexpression relaxin-2 gene (TAC + RLN2). A sham group was also included. Twelve days after intramyocardial injection, echocardiography and hemodynamics were carried out to evaluate diastolic function in sham, TAC, TAC + GFP and TAC + RLN2 groups. Then hearts were harvested for subsequent examinations. The results indicated that relaxin-2 had ameliorated diastolic function in the pressure-overloaded rats. Compared with the TAC and TAC + GFP groups, the relaxin-2 gene transfer increased phosphorylation of Akt at both the Ser473 and Thr308 sites. Meanwhile, it increased the Ser16 and Thr17- phosphorylation levels of phospholamban (PLB). Furthermore, SERCA2 activity was enhanced in the TAC + RLN2 group more than in the TAC and TAC + GFP groups.

Conclusions

These results demonstrated that relaxin-2 gene therapy improved diastolic function in pressure-overloaded rats. The potential mechanism may be that relaxin-2 gene transfer enhances SERCA2 activity in hearts by increasing phospholamban phosphorylation through nuclear-targeted Akt phosphorylation.